Becton Dickinson & Co (BDX)
225.45
+3.06
(+1.38%)
USD |
NYSE |
Nov 21, 16:00
225.44
-0.01
(-0.00%)
After-Hours: 20:00
Becton Dickinson Revenue (TTM): 20.18B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 20.18B |
| June 30, 2024 | 19.83B |
| March 31, 2024 | 19.72B |
| December 31, 2023 | 19.49B |
| September 30, 2023 | 19.37B |
| June 30, 2023 | 19.05B |
| March 31, 2023 | 18.81B |
| December 31, 2022 | 18.74B |
| September 30, 2022 | 18.87B |
| June 30, 2022 | 18.96B |
| March 31, 2022 | 18.92B |
| December 31, 2021 | 19.08B |
| September 30, 2021 | 19.68B |
| June 30, 2021 | 18.57B |
| March 31, 2021 | 17.82B |
| December 31, 2020 | 17.16B |
| September 30, 2020 | 16.07B |
| June 30, 2020 | 16.92B |
| March 31, 2020 | 17.41B |
| December 31, 2019 | 17.35B |
| September 30, 2019 | 17.29B |
| June 30, 2019 | 17.11B |
| March 31, 2019 | 17.04B |
| December 31, 2018 | 17.06B |
| September 30, 2018 | 15.98B |
| Date | Value |
|---|---|
| June 30, 2018 | 14.75B |
| March 31, 2018 | 13.50B |
| December 31, 2017 | 12.25B |
| September 30, 2017 | 12.09B |
| June 30, 2017 | 12.16B |
| March 31, 2017 | 12.32B |
| December 31, 2016 | 12.42B |
| September 30, 2016 | 12.48B |
| June 30, 2016 | 12.31B |
| March 31, 2016 | 12.23B |
| December 31, 2015 | 11.22B |
| September 30, 2015 | 10.28B |
| June 30, 2015 | 9.424B |
| March 31, 2015 | 8.461B |
| December 31, 2014 | 8.482B |
| September 30, 2014 | 8.446B |
| June 30, 2014 | 8.345B |
| March 31, 2014 | 8.241B |
| December 31, 2013 | 8.169B |
| September 30, 2013 | 8.054B |
| June 30, 2013 | 7.920B |
| March 31, 2013 | 7.847B |
| December 31, 2012 | 7.776B |
| September 30, 2012 | 7.708B |
| June 30, 2012 | 7.729B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
16.07B
Minimum
Sep 2020
20.18B
Maximum
Sep 2024
18.60B
Average
18.90B
Median
Revenue (TTM) Benchmarks
| Boston Scientific Corp | 15.91B |
| Abbott Laboratories | 41.22B |
| Baxter International Inc | 17.28B |
| Merit Medical Systems Inc | 1.326B |
| ResMed Inc | 4.807B |